Strategic Analysis of the 2026 Bioreactor Market: Process Intensification, Single-Use Technologies, and Digital Twins
As of February 2026, the global life sciences sector is characterized by a "bioprocessing revolution," with the Bioreactor Market serving as the engine for the mass production of monoclonal antibodies (mAbs), vaccines, and advanced therapy medicinal products (ATMPs). The industry has transitioned from rigid, stainless-steel paradigms toward flexible, modular, and highly automated cultivation...